Cargando…

Targeting the proteasome in epilepsy

Detalles Bibliográficos
Autores principales:	Engel, Tobias, Lucas, Jose J., Henshall, David C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542164/ https://www.ncbi.nlm.nih.gov/pubmed/28611313 http://dx.doi.org/10.18632/oncotarget.18418

Ejemplares similares

Spatiotemporal progression of ubiquitin-proteasome system inhibition after status epilepticus suggests protective adaptation against hippocampal injury
por: Engel, Tobias, et al.
Publicado: (2017)

Targeting microRNA-134 for seizure control and disease modification in epilepsy
por: Morris, Gareth, et al.
Publicado: (2019)

Contribution of apoptosis-associated signaling pathways to epileptogenesis: lessons from Bcl-2 family knockouts
por: Henshall, David C., et al.
Publicado: (2013)

Notch versus the proteasome: what is the target of γ-secretase inhibitor-I?
por: Clementz, Anthony G, et al.
Publicado: (2009)

Pathogenesis and Targeted Therapy of Epilepsy
por: N’Gouemo, Prosper
Publicado: (2022)

Regulating Proteasome Activity
por: Cascio, Paolo, et al.
Publicado: (2022)

P2X receptors as targets for the treatment of status epilepticus
por: Henshall, David C., et al.
Publicado: (2013)

Circulating P2X7 Receptor Signaling Components as Diagnostic Biomarkers for Temporal Lobe Epilepsy
por: Conte, Giorgia, et al.
Publicado: (2021)

Ubiquitin Proteasome System in Stress and Disease
por: Karpov, Dmitry, et al.
Publicado: (2012)

Cancer cachexia—when proteasomal inhibition is not enough
por: Fielitz, Jens
Publicado: (2016)

The Metabotropic Purinergic P2Y Receptor Family as Novel Drug Target in Epilepsy
por: Alves, Mariana, et al.
Publicado: (2018)

The Multifaceted Role of the Ubiquitin Proteasome System in Pathogenesis and Diseases
por: Stekel, Zane, et al.
Publicado: (2022)

miRNA-Mediated Regulation of Adult Hippocampal Neurogenesis; Implications for Epilepsy
por: Bielefeld, Pascal, et al.
Publicado: (2017)

Discovery and validation of blood microRNAs as molecular biomarkers of epilepsy: Ways to close current knowledge gaps
por: Enright, Noelle, et al.
Publicado: (2018)

Targeting Neuroinflammation via Purinergic P2 Receptors for Disease Modification in Drug-Refractory Epilepsy
por: Engel, Tobias, et al.
Publicado: (2021)

Disruption of the Ubiquitin-Proteasome System and Elevated Endoplasmic Reticulum Stress in Epilepsy
por: Poliquin, Sarah, et al.
Publicado: (2022)

Novel mechanism of drug resistance to proteasome inhibitors in multiple myeloma
por: Zhou, Jianbiao, et al.
Publicado: (2019)

Boosting autophagy in anti-tumor proteasome inhibition-mediated cardiotoxicity
por: Papanagnou, Eleni-Dimitra, et al.
Publicado: (2023)

The ATP-Gated P2X7 Receptor As a Target for the Treatment of Drug-Resistant Epilepsy
por: Beamer, Edward, et al.
Publicado: (2017)

The proteasome and the degradation of oxidized proteins: Part I—structure of proteasomes()
por: Jung, Tobias, et al.
Publicado: (2013)

Diet in the Treatment of Epilepsy
por: Westmark, Cara J.
Publicado: (2021)

Ubiquitin–proteasome system involvement in Huntington’s disease
por: Ortega, Zaira, et al.
Publicado: (2014)

Ubiquitination and the Proteasome as Drug Targets in Trypanosomatid Diseases
por: Bijlmakers, Marie-José
Publicado: (2021)

Sleep and Epilepsy
por: Romigi, Andrea, et al.
Publicado: (2013)

Microbial proteasomes as drug targets
por: Zhang, Hao, et al.
Publicado: (2021)

The P2X7 Receptor as a Mechanistic Biomarker for Epilepsy
por: Engel, Tobias
Publicado: (2023)

Large scale RNAi screen in Tribolium reveals novel target genes for pest control and the proteasome as prime target
por: Ulrich, Julia, et al.
Publicado: (2015)

Validation of Babesia proteasome as a drug target
por: Jalovecka, Marie, et al.
Publicado: (2018)

Epilepsy and Disorders of Consciousness
por: Cavanna, Andrea Eugenio
Publicado: (2011)

The Modern Treatment of Epilepsy
Publicado: (1901)

Special Provision for Epilepsy
Publicado: (1893)

Long-range allosteric regulation of the human 26S proteasome by 20S proteasome-targeting cancer drugs
por: Haselbach, David, et al.
Publicado: (2017)

Epilepsy Benchmarks Area III: Improved Treatment Options for Controlling Seizures and Epilepsy-Related Conditions Without Side Effects
por: Traynelis, Stephen F., et al.
Publicado: (2020)

Beyond Seizure Control: Treating Comorbidities in Epilepsy via Targeting of the P2X7 Receptor
por: Gil, Beatriz, et al.
Publicado: (2022)

Genetic deletion of microRNA-22 blunts the inflammatory transcriptional response to status epilepticus and exacerbates epilepsy in mice
por: Almeida Silva, Luiz F., et al.
Publicado: (2020)

The proteasome and the degradation of oxidized proteins: Part III—Redox regulation of the proteasomal system
por: Höhn, Tobias Jung Annika, et al.
Publicado: (2014)

The proteasome and the degradation of oxidized proteins: Part II – protein oxidation and proteasomal degradation
por: Jung, Tobias, et al.
Publicado: (2013)

Editorial: The molecular mechanisms of epilepsy and potential therapeutics
por: Engel, Tobias, et al.
Publicado: (2022)

Profile of neurologists in Brazil: a glimpse into the future of epilepsy and sudden unexpected death in epilepsy
por: Amorim, Henrique A., et al.
Publicado: (2013)

Challenges in Decoding Sudden Unexpected Death in Epilepsy: The Intersection Between Heart and Brain in Epilepsy
por: Asatryan, Babken
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_k1kl2ocurlegtdj4ofetb7pegg